Market Place
Sourcing Support
eFFECTOR, Dana-Farber To Study Zotatifin ER+ Endo/Ovarian Cancer Combo
20 May 2024 //
GLOBENEWSWIRE
eFFECTOR Therapeutics Announces Data from Phase 2 Expansion Cohorts of Zotatifin
08 Dec 2023 //
GLOBENEWSWIRE
eFFECTOR Receives U.S. FDA Fast Track Designation for Zotatifin
28 Nov 2023 //
GLOBENEWSWIRE
eFFECTOR to Present Data from Phase 2 Expansion Cohorts of Zotatifin
15 Nov 2023 //
GLOBENEWSWIRE
eFFECTOR Therapeutics Announces Results from Phase 1b Trial of Zotatifin
21 Feb 2023 //
GLOBENEWSWIRE
eFFECTOR reports positive data from trial of zotatifin for Covid-19
21 Feb 2023 //
CLINICAL TRIALS ARENA
eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin
05 Jan 2023 //
GLOBENEWSWIRE
eFFECTOR Doses First Patient in Second Cohort of Pha 1b Trial of Zotatifin
14 Sep 2022 //
GLOBENEWSWIRE
eFFECTOR Reports Positive Interim Results in Zotatifin PI/II Trial at ASCO 2022
05 Jun 2022 //
GLOBENEWSWIRE
eFFECTOR to Present Interim Data from Ongoing Zotatifin PI/II Trial
26 May 2022 //
GLOBENEWSWIRE
Scientists Tested 47 Existing Drugs And Found Potential New Ways to Fight Covid
04 May 2020 //
SCIENCEALERT
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.